July 30 Pfizer Inc, the largest U.S.
drugmaker, reported second-quarter adjusted income slightly
ahead of analysts' estimates and reaffirmed its financial
outlook for the year.
For the second quarter, Pfizer's adjusted income fell 10
percent to $4.00 billion, or 56 cents a share, from $4.45
billion, or 59 cents a share, a year earlier.
Revenue fell 7 percent to $12.97 billion.
Analysts, on average, were expecting second-quarter income
of 55 cents a share, on revenue of $13.01 billion, according to
Thomson Reuters I/B/E/S.